Angiotensin II Type 1 Receptor Antagonist Candesartan as an Angiogenic Inhibitor in a Xenograft Model of Bladder Cancer
M. Kosugi, A. Miyajima, E. Kikuchi, Y. Horiguchi, M. Murai
Clinical Cancer Research